tiprankstipranks
Trending News
More News >
Century Therapeutics, Inc. (IPSC)
:IPSC
US Market

Century Therapeutics (IPSC) Income Statement

Compare
191 Followers

Century Therapeutics Income Statement

Last quarter (Q1 2025), Century Therapeutics's total revenue was $109.16M, an increase of 12667.72% from the same quarter last year. In Q1, Century Therapeutics's net income was $76.56M. See Century Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.59M$ 2.23M$ 5.20M$ 0.00$ 0.00
Gross Profit
$ 6.59M$ 2.23M$ -4.87M$ -4.58M$ -1.75M
Operating Expenses
$ 144.73M$ 148.78M$ 139.03M$ 94.88M$ 49.18M
Depreciation and Amortization
$ 13.30M$ 13.04M$ 10.07M$ 4.58M$ 1.75M
EBITDA
$ -111.47M$ -121.21M$ -119.34M$ -89.92M$ -51.44M
Operating Income
$ -138.14M$ -146.55M$ -133.83M$ -94.88M$ -53.90M
Other Income/Expenses
$ 13.36M$ 11.75M$ 2.99M$ -898.00K$ 323.00K
Pretax Income
$ -124.78M$ -134.79M$ -130.84M$ -95.78M$ -53.58M
Net Income
$ -126.57M$ -136.67M$ -130.93M$ -95.82M$ -54.66M
Per Share Metrics
Basic EPS
$ -1.61$ -2.30$ -2.27$ -1.74$ -1.00
Diluted EPS
$ -1.61$ -2.30$ -2.27$ -1.74$ -1.00
Weighted Average Shares Outstanding
78.65M 59.31M 57.76M 55.01M 54.82M
Weighted Average Shares Outstanding (Diluted)
78.65M 59.31M 57.76M 55.01M 54.82M
Currency in USD

Century Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis